Audrey F. Saftlas Professor INSTITUTION AND LOCATION FIELD OF STUDY
Positions and Employment 1979-1980
Research Associate, Michigan State Toxic Substance Control Commission, Lansing, MI
Epidemiologist, Michigan Cancer Foundation Registry (SEER), Detroit, MI
Epidemiologist (COSTEP), Occupational Studies Section, Environmental Epidemiology Branch, National Cancer Institute, Bethesda, MD
Guest Scientist, Environmental Studies Section, Environmental Epidemiology Branch, National Cancer Institute, Bethesda, MD
Epidemic Intelligence Service (EIS) Officer, Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, GA
Epidemiologist, Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, GA
Epidemiologist (CDC) and Adjunct Assistant Professor, Department of Community Health Sciences, UCLA School of Public Health, Los Angeles, CA
Associate Research Scientist, Division of Chronic Disease Epidemiology, Dept of Epidemiology and Public Health, Yale School of Medicine, New Haven, CT
Assistant Professor, Division of Chronic Disease Epidemiology, Dept of Epidemiology and Public Health, Yale School of Medicine, New Haven, CT
1998-2000 Assistant Professor, Department of Epidemiology, University of Iowa, Iowa City, IA 2000-2004
Associate Professor, Department of Epidemiology, University of Iowa, Iowa City, IA
Professor, Department of Epidemiology, University of Iowa, Iowa City, IA
Other Experience and Professional Memberships 1979-
Member, Society for Epidemiologic Research
Scientific Advisory Committee, Perinatal Epidemiological Research Initiative, March of Dimes
Birth Defects Foundation, White Plains, NY
Society for Perinatal and Pediatric Epidemiologic Research
Member, North American Society for the Study of Hypertension in Pregnancy
Associate Editor, American Journal Epidemiology
Chartered Member, NIH, Epidemiology of Chronic Diseases Study Section (ECD)
Epidemiology Section Counselor, American Public Health Association
Acting Editor, American Journal of Epidemiology
Member, Special Emphasis Panel (SEP) in response to RFA DP-06-002, Pregnancy Risk Assessment Monitoring System (PRAMS), CDC, Atlanta, February 15-17, 2006
Invited Faculty, Society for Epidemiologic Research (SER) Student Workshop, Seattle, WA
Invited Participant, NICHD Workshop: “Preeclampsia—A Pressing Problem”
Centers for Disease Control and Prevention, Scientific Review Group: ZCD1 CJM (07),
PAR07-231 (Panel C), Dissertation Grant Reviews, April 28-29, 2009
Consensus Development Panelist, NIH State-of-the- Science Conference
Diagnosis and Management of Ductal Carcinoma in Situ (DCIS) September 22-24, 2009
Research Member, Preeclampsia Foundation
Society for Advancement of Violence and Injury Research (SAVIR), Center Member
Epidemiology Section Editor, Aesthetic Plastic Surgery
Honors 1977-1979
Predoctoral Research Training Grant, NIH, DHEW
National Research Service Award (postdoctoral), NCI
National Research Service Award (predoctoral), NCI
Member, Delta Omega Public Health Honor Society (UCLA Chapter)
Who’s Who in Health Sciences Education (Academic Keys)
Selected Peer-reviewed Publications (selected from over 60 publications)
1. Sadler L, Saftlas AF. Pregnancy risks associated with LEEP. Contemporary OB/GYN 2006,
2. Beydoun H, Saftlas AF, Harland K, Triche E. Combining conditional and unconditional recruitment
incentives could facilitate telephone tracing in surveys of postpartum women. Journal of Clinical Epidemiology 2006, 59(7):732-738.
National Institutes of Health State-of-the-Science Conference Statement: Multivitamin/Mineral Supplements and Chronic Disease Prevention. Annals of Internal Medicine 2006; 145(5):264-37.
*Also published in: Am J Clin Nutr 85(suppl):257S-64S, 2007.
4. Sadler L, Saftlas A. Cervical surgery and preterm birth. J Perinat Med 2007, 35(1):5-9.
5. Wallis AB, Saftlas AF. Untangling an epidemiological knot: migraine and preeclampsia (Reviewer
commentary). Am J Hypertens 2008, Mar;21:245.
6. Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rate of preeclampsia, eclampsia,
and gestational hypertension, United States, 1987-2004. Am J Hypertens 2008, 21(5):521-6.
7. Wallis AB, Saftlas AF. A Gram of Prevention…A Modest Increase in Fiber Consumption May
Reduce Risk of Preeclampsia (Reviewer commentary). Am J Hypertens 2008, 21(8):849-850, 2008.
8. Beydoun H, Saftlas AF. Physical and mental health outcomes of prenatal maternal stress in
human and animal studies: A review of recent evidence. Paedatric and Perinatal Epidemiology 2008, 22(5):438-466.
9. Wallis AB, Saftlas AF. Reviewer commentary: Is there a relationship between prenatal depression
and preeclampsia? Am J Hypertens 2009, 22(4):345-346.
10. Allegra CJ, Aberle DR, Ganschow P, Hahn SM, Lee CN, Millon-Underwood S, Pike MC, Reed SD,
Saftlas AF, Scarvalone SA, Schwartz AM, Slomski C, Yothers G, Zon R. NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS). NIH Consens State Sci Statements 2009, 26(2):1-27.
11. Allegra CJ, Aberle DR, Ganschow P, Hahn SM, Lee CN, Millon-Underwood S, Pike MC, Reed SD,
Saftlas AF, Scarvalone SA, Schwartz AM, Slomski C, Yothers G, Zon R.J Natl Cancer Inst 2010, 102(3):161-169.
12. Kuntz JL, Yang M, Cavanaugh JE, Saftlas AF, Polgreen PM. Trends in Clostridium difficile infection
among peripartum women. Infect Control Hosp Epidemiol 2010, 31(5):532-4.
13. Saftlas AF, Wallis AB, Shochet T, Harland KK, Dickey P, Peek-Asa C. Prevalence of Intimate
Partner Violence in an Abortion Clinic Population. Am J Public Health: 2010 Aug:100(8):1412-5. Epub 2010 Jun 17.
14. Saftlas AF, Triche EW, Baydoun H, Bracken MB. Does chocolate intake during pregnancy reduce
the risks of preeclampsia and gestational hypertension? Ann Epidemiol 2010 Aug:20(8):584-91.
15. Beyer KM, Saftlas AF, Wallis AB, Peek-Asa C, Rushton G. A probabilistic sampling method (PSM)
for estimating geographic distance to health services when only the region of residence is known. International Journal of Health Geographics 2011:10:4.
16. TePoel, M, Saftlas, AF, Wallis, AB. Association of seasonality with hypertension in pregnancy: A
systematic review. Journal of Reproductive Immunology 2011, 89(2):140-52.
17. Robillard PY, Dekker GA, Chaouat G, Hulsey TC, Saftlas A. Epidemiological studies on
primipaternity and immunology in preeclampsia—a statement after twelve years of workshops. Journal of Reproductive Immunology 2011, 89(2):104-17.
18. Peek-Asa C, Wallis A, Harland K, Beyer K, Dickey P, Saftlas A. Rural disparity in domestic
violence: Prevalence and access to resources. J Womens Health 2011, 20(11):1743-9.
19. Colaizy TT, Saftlas AF, Morriss FH. Maternal intention to breast-feed and breast-feeding outcomes
in term and preterm infants: Pregnancy risk assessment monitoring system (PRAMS), 2000-2003. Public Health Nutr 2012, 15(4):702-10.
20. Harland KK, Saftlas AF Wallis AB, Yankowitz J, Peek-Asa C, Zimmerman MB. Correction of
systematic bias in ultrasound dating in studies of small-for-gestational-age: An Example from the Iowa Health in Pregnancy Study. Am J Epidemiol 2012, 176(5):443-55.
21. Zhao L, Triche EW, Walsh KM, Bracken MB, Saftlas AF, Hoh J, Dewan AT. Genome-wide
association study identifies a maternal copy-number deletion in PSG11 enriched among preclampsia patients. BMC Pregnancy Childbirth 2012, 12(1):61.
22. Colaizy TT, Carlson S, Saftlas AF, Morriss FH Jr. Growth in VLBW infants fed predominantly
fortified maternal and donor human milk diets: a retrospective cohort study. BMC Pediatr 2012, 12:124.
Chapters
1. Rigterink ES, Saftlas AF, Atrash HK. Induced Abortion. In: Women and Health (2nd Edition), 2012
www.pos-equinos.com.br 1. Current wound management practices that influence wound infection and healing Ted S Stashak DVM, MS, Diplomate ACVS, Professor Emeritus Surgery, Colorado State University Introduction Infection is defined as the presence of replicating microorganisms in a wound, leading to subsequent host injury. It should be distinguished from wound contamination wh
MODELO DE BULA DO PACIENTE IDENTIFICAÇÃO DO MEDICAMENTO COVERSYL 4mg perindopril 4mg APRESENTAÇÕES: Embalagem contendo 15 ou 30 comprimidos de 4mg. USO ORAL USO ADULTO ACIMA DE 18 ANOS COMPOSIÇÃO: Cada comprimido de COVERSYL (perindopril) 4mg contém: perindopril, sal de terc-butilamina. 4,00 mg. correspondente a 3,338 mg de perindopril(DCB 06994). excipiente